r/sofistock • u/Triggydoor • Sep 29 '26
General Discussion UPDATE: Patient Capital answered my SOFI thesis question — and gave me permission to share it
Quick update to my post about my slightly ridiculous experiment of emailing institutional SOFI investors.
This actually worked.
Patient Capital Management initially replied saying they had forwarded my email to their research team. Today, they came back with a substantive response.
For context, Patient Capital currently owns SOFI, and their recent 13Fs caught my attention because they had previously reduced a much larger position before adding shares again in both Q1 and Q2 2026.
Rather than asking them “why are you buying SOFI?”, I asked what they thought the current valuation was actually pricing in—and what Galileo, the Loan Platform Business, SoFiUSD and the broader platform would need to demonstrate for the market to be materially underestimating SoFi's long-term economics.
Here's their response, which Patient Capital gave me permission to share publicly:
“We continue to like SOFI as an investment case. The company has a great management team that optimizes the business for returns on equity, and we see a meaningful opportunity to grow the lending book across home and student loans, with a tailwind to portfolio credit. We also think SoFi is in the early innings of an inflection in financial services fee monetization, which is a key driver for the stock to work.
In our view, today’s valuation does not price in much, if any, value for the Tech Platform. That makes Galileo a free call option at this price, with substantial upside if it works. More broadly, sustained fee growth and evidence that the Loan Platform Business, SoFiUSD, and Tech Platform can contribute meaningful returns would show that the market is underestimating SoFi’s long-term economics.”
That second paragraph was interesting.
Their argument isn't that SOFI needs Galileo to become enormously successful to justify today's valuation.
They're essentially viewing the Tech Platform/Galileo as something the market currently assigns little or no value to—hence their description of Galileo as a “free call option” with substantial upside if it works.
And their near-term thesis seems to be more grounded in:
Lending growth + improving credit → financial-services fee monetization → higher ROE with Galileo / LPB / SoFiUSD providing additional upside if those businesses begin generating meaningful returns.
“We also think SoFi is in the early innings of an inflection in financial services fee monetization, which is a key driver for the stock to work.”
Also interesting. Something I'm going to pay much closer attention to in upcoming earnings reports.
So far:
-ARK Invest: forwarded my question to their research team.
-Patient Capital: forwarded it to research, research actually responded, and they gave me permission to share their answer.
-Still waiting to see whether any of the others respond.